Therapeutic approaches for muscle wasting disorders
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 113 (3) , 461-487
- https://doi.org/10.1016/j.pharmthera.2006.11.004
Abstract
No abstract availableKeywords
This publication has 388 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor LigandsPharmaceutical Research, 2006
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006
- Deficiency of the Bax gene attenuates denervation-induced apoptosisApoptosis, 2006
- Muscle wasting in cardiac cachexiaThe International Journal of Biochemistry & Cell Biology, 2005
- Novel aspects on the regulation of muscle wasting in sepsisThe International Journal of Biochemistry & Cell Biology, 2005
- Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistanceThe International Journal of Biochemistry & Cell Biology, 2005
- Characterization of the β-Dystroglycan–Growth Factor Receptor 2 (Grb2) InteractionBiochemical and Biophysical Research Communications, 2000
- Interleukin-15 Stimulates C2 Skeletal Myoblast DifferentiationBiochemical and Biophysical Research Communications, 1997
- Fibroblast growth factor, epidermal growth factor, insulin‐like growth factors, and platelet‐derived growth factor‐BB stimulate proliferation of clonally derived porcine myogenic satellite cellsJournal of Cellular Physiology, 1993
- Localization of the Ca2+‐dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscleThe Anatomical Record, 1992